The same active ingredient in Wegovy®* and Ozempic®*

Semaglutide is indicated for use in adults with a body mass index (BMI) of 30 or more, or in adults with a BMI of 27 or more who have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.

It’s important to note that Semaglutide is not a magic pill and should be used in conjunction with diet and exercise for the best results. It’s also not recommended in pregnant or breastfeeding women or individuals with a personal or family history of medullary thyroid carcinoma.

Semaglutide is administered as a once-weekly, self-administered, subcutaneous injection (under the skin). The starting dosage is 0.25 mg per week for four weeks, then increased to 0.5 mg per week for another four weeks. The maintenance dose is 1.0 mg per week.

It’s important to follow the prescribed dosing schedule and not to change the dose without consulting your healthcare provider.

Common side effects include nausea, diarrhea, vomiting, and constipation. These side effects usually improve over time and can be managed with dietary changes, drinking plenty of fluids, and over-the-counter medications if necessary.

More serious but rare side effects include pancreatitis, gallbladder disease, an increased risk of thyroid cancer, and allergic reactions. Your healthcare provider should monitor you for these side effects while you are on Semaglutide.

Semaglutide has been shown to be effective in promoting weight loss in clinical trials. A study published in the New England Journal of Medicine reported an average weight loss of 15% in participants over one year.

However, it’s important to note that Semaglutide is a new drug, and its long-term effects are still unknown. It’s also not a substitute for a healthy lifestyle. It is important to maintain healthy eating and exercise habits even after stopping the medication.